The Role of G Protein-Coupled Estrogen Receptor (GPER) in Vascular Pathology and Physiology

被引:13
作者
Xu, Fujie [1 ,2 ]
Ma, Jipeng [2 ]
Wang, Xiaowu [2 ]
Wang, Xiaoya [2 ]
Fang, Weiyi [1 ,2 ]
Sun, Jingwei [1 ,2 ]
Li, Zilin [2 ]
Liu, Jincheng [2 ]
机构
[1] Xian Med Univ, Xian 710068, Peoples R China
[2] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China
基金
中国国家自然科学基金;
关键词
G protein-coupled estrogen receptor (GPER); estrogen; hypertension; atherosclerosis; inflammation; lipid metabolism; NEGATIVE BREAST-CANCER; GROWTH-FACTOR RECEPTOR; SMOOTH-MUSCLE-CELLS; GENE-EXPRESSION CHANGES; BISPHENOL-A; ENDOTHELIAL-CELLS; UP-REGULATION; PULMONARY-HYPERTENSION; BLOOD-PRESSURE; NITRIC-OXIDE;
D O I
10.3390/biom13091410
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Objective: Estrogen is indispensable in health and disease and mainly functions through its receptors. The protection of the cardiovascular system by estrogen and its receptors has been recognized for decades. Numerous studies with a focus on estrogen and its receptor system have been conducted to elucidate the underlying mechanism. Although nuclear estrogen receptors, including estrogen receptor-& alpha; and estrogen receptor-& beta;, have been shown to be classical receptors that mediate genomic effects, studies now show that GPER mainly mediates rapid signaling events as well as transcriptional regulation via binding to estrogen as a membrane receptor. With the discovery of selective synthetic ligands for GPER and the utilization of GPER knockout mice, significant progress has been made in understanding the function of GPER. In this review, the tissue and cellular localizations, endogenous and exogenous ligands, and signaling pathways of GPER are systematically summarized in diverse physiological and diseased conditions. This article further emphasizes the role of GPER in vascular pathology and physiology, focusing on the latest research progress and evidence of GPER as a promising therapeutic target in hypertension, pulmonary hypertension, and atherosclerosis. Thus, selective regulation of GPER by its agonists and antagonists have the potential to be used in clinical practice for treating such diseases.
引用
收藏
页数:24
相关论文
共 207 条
  • [101] Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
    Kuiper, GGJM
    Carlsson, B
    Grandien, K
    Enmark, E
    Haggblad, J
    Nilsson, S
    Gustafsson, JA
    [J]. ENDOCRINOLOGY, 1997, 138 (03) : 863 - 870
  • [102] Two Novel GPER Agonists Induce Gene Expression Changes and Growth Effects in Cancer Cells
    Lappano, R.
    Rosano, C.
    Santolla, M. F.
    Pupo, M.
    De Francesco, E. M.
    De Marco, P.
    Ponassi, M.
    Spallarossa, A.
    Ranise, A.
    Maggiolini, M.
    [J]. CURRENT CANCER DRUG TARGETS, 2012, 12 (05) : 531 - 542
  • [103] Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells
    Lappano, Rosamaria
    Rosano, Camillo
    De Marco, Paola
    De Francesco, Ernestina Marianna
    Pezzi, Vincenzo
    Maggiolini, Marcello
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 320 (1-2) : 162 - 170
  • [104] Activation of GPR30 stimulates GTP-binding of Gαi1 protein to sustain activation of Erk1/2 in inhibition of prostate cancer cell growth and modulates metastatic properties
    Lau, Kin-Mang
    Ma, Fanny Man-Ting
    Xia, Jenny Tian
    Chan, Queeny Kwan Yi
    Ng, Chi-Fai
    To, Ka-Fai
    [J]. EXPERIMENTAL CELL RESEARCH, 2017, 350 (01) : 199 - 209
  • [105] Lee Hye-Rim, 2012, Lab Anim Res, V28, P71, DOI 10.5625/lar.2012.28.2.71
  • [106] G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection
    Lenhart, Patricia M.
    Broselid, Stefan
    Barrick, Cordelia J.
    Leeb-Lundberg, L. M. Fredrik
    Caron, Kathleen M.
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2013, 51 (01) : 191 - 202
  • [107] Activation of GPER Induces Differentiation and Inhibition of Coronary Artery Smooth Muscle Cell Proliferation
    Li, Fen
    Yu, Xuan
    Szynkarski, Claudia K.
    Meng, Cong
    Zhou, Beiyan
    Barhoumi, Rola
    White, Richard E.
    Heaps, Cristine L.
    Stallone, John N.
    Han, Guichun
    [J]. PLOS ONE, 2013, 8 (06):
  • [108] Li HY, 2000, J PHARMACOL EXP THER, V293, P592
  • [109] Bisphenol AF-Induced Endogenous Transcription Is Mediated by ERα and ERK1/2 Activation in Human Breast Cancer Cells
    Li, Ming
    Guo, Jing
    Gao, Wenhui
    Yu, Jianlong
    Han, Xiaoyu
    Zhang, Jing
    Shao, Bing
    [J]. PLOS ONE, 2014, 9 (04):
  • [110] Improvement of Vascular Function by Acute and Chronic Treatment with the GPR30 Agonist G1 in Experimental Diabetes Mellitus
    Li, Zi-lin
    Liu, Jin-cheng
    Liu, Shui-bing
    Li, Xiao-qiang
    Yi, Ding-hua
    Zhao, Ming-gao
    [J]. PLOS ONE, 2012, 7 (06):